Clinical Trial Update: Integrative Sequencing In Germline and Hereditary Tumours

View source ↗

Summary

This entry describes a clinical trial evaluating integrative sequencing in germline and hereditary tumors, sponsored by University Health Network in Toronto. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Cancer Syndrome

Snippet

Sponsor: University Health Network, Toronto | Conditions: Hereditary Cancer Syndrome, High-Risk | Status: ACTIVE_NOT_RECRUITING